Abstract
When human neutrophils (PMNs) are activated by appropriate stimuli, they aggregate, generate Superoxide anion (O −2 ) and secrete lysosomal enzymes. Pre-incubation of PMNs in vitro with the cyclo-oxygenase (COx) inhibitor piroxicam (50μM) before stimulation with the chemotactic peptide f-met-leu-phe (FMLP, 10−7 M) inhibited all of these responses. The COx inhibitor ibuprofen inhibited FMLP-induced aggregation and lysozyme secretion, leaving O −2 generation unaffected. Binding of3H-FMLP was inhibited by piroxicam. When the plant iectin concanavalin A (Con-A, 30μg/ml) or the tumor promoter phorbol myristate acetate (PMA, 50μml) was used as a stimulus, ibuprofen had no effect on PMN response, while piroxicam inhibited only O −2 generation. To determine whether such inhibition might also occur in vivo, we tested neutrophil aggregation and O −2 generation in response to FMLP in 26 normal subjects. These subjects were then administered therapeutic doses of piroxicam (20 mg/ day), ibuprofen (2400 mg/day) or indomethacin (100 mg/day), and neutrophil functions were retested after 3 days. Piroxicam inhibited FMLP-induced aggregation by 31% (5.2 cm2/min versus 3.6cm2/min,P<0.004) and O −2 generation by 35% (15.8 nmol cytochrorae c reduced versus 10.2 nmol,P<0.002). Ibuprofen inhibited FMLP-induced aggregation by 44% (5.2 versus 3.0,P<0.03) but had no effect on O −2 production. Indomethacin inhibited FMLP-induced aggregation (6,4 versus 2.9,P<0.01) but had no effect on O −2 generation. These studies suggest that: (a) multiple pathways exist for the activation of the neutrophil, since inhibition by non-steroidal anti-inflammatory drugs (NSAIDs) is stimulus-dependent; (b) NSAIDs have cellular effects that are not dependent on COx inhibition; (c) unique effects on cellular function may account for the clinical variability in responsiveness to different NSAIDs.
Similar content being viewed by others
References
Mohr, W., andD. Wessinghage. 1978. The relationship between polymorphonuclear granulocytes and cartilage destruction in rheumatoid arthritis.Z. Reichtsmed. 37:81.
Weissmann, G., I. Spilberg, andK. Krakauer. 1969. Arthritis induced in rabbits by lysates of granulocyte lysosomes.Arthritis Rheum. 12:103.
Weissmann, G., andI. Spilberg. 1968. Breakdown of cartilage protein polysaccharide by lysosomes.Arthritis Rheum. 9:162.
Desmukh, K., andS. Hemrick. 1976. Metabolic changes in rabbit articular cartilage due to inflammation.Arthritis Rheum. 19:199.
Goldberg, B., andA. Stern. 1975. The generation of O −2 by the interaction of the hemolytic agent phenylhydrazine with human hemoglobin.J. Biol. Chem. 250:2401.
Slirvinski, A. H., andN. H. Zvaifler. 1970. In vivo synthesis of IgG by rheumatoid synovium.J. Lab. Clin. Med. 76:304.
Harris, E. D., Jr., C. S. Faulkner, III, andF. E. Brown. 1975. Collagenolytic systems in rheumatoid arthritis.Clin. Orthop. 110:303.
Menninger, H., R. Putzier, W. Mohr, D. Wessinghage, andK. Tillman. 1980. Granulocyte elastase at the site of cartilage erosion by rheumatoid synovial tissue.J. Rheumatol. 39:145–156.
Kaplan, H., H. Edelson, R. Friedman, andG. Weissmann. 1982. The roles of degranulation and Superoxide generation in neutrophil aggregation.Biochim. Biophys. Acta. 721:55.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abramson, S., Edelson, H., Kaplan, H. et al. The inactivation of the polymorphonuclear leukocyte by non-steroidal anti-inflammatory drugs. Inflammation 8 (Suppl 1), S103–S108 (1984). https://doi.org/10.1007/BF00915717
Issue Date:
DOI: https://doi.org/10.1007/BF00915717